Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 169,552 | reported | 26 Jun 2019 | tx 64+1,077,516−474,671 |
| Intellia Therapeutics, Inc. | 134,693 | reported | 20 Aug 2025 | tx 9+168,236 |
| GRAIL, Inc. | 36,803 | reported | 15 Jan 2026 | tx 9+36,803 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2026 | GRANT_AWARD | GRAIL, Inc. | 213 | 97.44 USD | |
| 15 Oct 2025 | GRANT_AWARD | GRAIL, Inc. | 275 | 75.52 USD | |
| 20 Aug 2025 | PURCHASE | Intellia Therapeutics, Inc. | 100,000 | 10.03 USD | first after silence |
| 15 Jul 2025 | GRANT_AWARD | GRAIL, Inc. | 533 | 38.53 USD | |
| 11 Jun 2025 | GRANT_AWARD | Intellia Therapeutics, Inc. | 8,000 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Intellia Therapeutics, Inc. | 11,450 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | GRAIL, Inc. | 6,082 | 41.10 USD | |
| 15 Apr 2025 | GRANT_AWARD | GRAIL, Inc. | 784 | 25.94 USD | |
| 15 Jan 2025 | GRANT_AWARD | GRAIL, Inc. | 1,182 | 17.58 USD | |
| 30 Oct 2024 | GRANT_AWARD | GRAIL, Inc. | 210 | 13.62 USD | |
| 15 Oct 2024 | GRANT_AWARD | GRAIL, Inc. | 1,054 | 14.01 USD | |
| 25 Jun 2024 | GRANT_AWARD | GRAIL, Inc. | 26,470 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 7,737 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 11,515 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 1,673 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 2,447 | 0.00 USD | deriv |
| 14 Apr 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 10,483 | 0.00 USD | |
| 14 Apr 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 14,931 | 0.00 USD | deriv |
| 26 Jun 2019 | PURCHASE | AbbVie Inc. | 30,400 | 67.30 USD | |
| 28 Feb 2019 | TAX_WITHHOLDING | AbbVie Inc. | 27,276 | 79.41 USD | |
| 21 Feb 2019 | GRANT_AWARD | AbbVie Inc. | 15,945 | 0.00 USD | |
| 21 Feb 2019 | GRANT_AWARD | AbbVie Inc. | 14,989 | 0.00 USD | |
| 21 Feb 2019 | GRANT_AWARD | AbbVie Inc. | 8,481 | 0.00 USD | |
| 21 Feb 2019 | GRANT_AWARD | AbbVie Inc. | 22,150 | 0.00 USD | |
| 21 Feb 2019 | GRANT_AWARD | AbbVie Inc. | 60,747 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2025.